InsideArbitrage Potential Deal Alert: Merck (MRK) Held Talks to Buy Swiss Biotech MoonLake (MLTX) for More Than $3 Billion
The Financial Times reported that Merck (MRK) has held talks over a more than $3 billion acquisition of Swiss biotechnology group MoonLake Immunotherapeutics (MLTX). The
Read More